Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Obesity Surgery Devices 2017 Global Market Report Analysis & Forecasts 2013-2023

Research and Markets
Posted on: 16 Mar 18
Obesity Surgery Devices 2017 Global Market Report Analysis & Forecasts 2013-2023

PR Newswire

DUBLIN, March 16, 2018

DUBLIN, March 16, 2018 /PRNewswire/ --

The "Obesity Surgery Devices Market by Procedure (Gastric Bypass, Sleeve Gastrectomy, Gastric Banding, BPD-DS, Non-Invasive Surgery), by Type, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023" report has been added to ResearchAndMarkets.com's offering.

The boost in demand for the obesity surgery devices is due to various factors such as increasing prevalence of obesity leading to high demand for obesity surgeries, rising awareness about bariatric surgery in obese population, lifestyle changes leading to high risk of obesity, and technological advancements in the obesity surgery devices industry.

The different minimally invasive surgeries performed are sleeve gastrectomy, gastric bypass, gastric banding, biliopancreatic diversion surgeries with a duodenal switch (BPD-DS) and several others. Sleeve gastrectomy surgery devices held the largest share in the obesity surgery devices market, since these surgeries result in more weight loss and have a low mortality rate, when compared to other alternative surgical procedures. The market for sleeve gastrectomy is expected to witness the fastest growth during the forecast period at a CAGR of 13.2%.

Obesity surgery is performed using several devices that are available in the market including stapling devices, gastric bands, gastric balloons, gastric electric stimulators and several others. Stapling devices held the largest share of the global obesity surgery devices market in 2016, owing to their high application in almost all types of bariatric surgeries to staple the stomach and intestine parts.

Asia-Pacific is expected to observe the fastest growth in the obesity surgery devices market, due to increasing aging population, rising prevalence of obesity, and booming medical tourism in the region. According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), the number of people aged 65 years and above constituted approximately 11.4% of population in 2013, and the count is estimated to reach approximately 20% of the population, by 2050. As a result, an increase in the demand for devices for obesity surgery is expected to increase in the region.

Also, according to the Organization for Economic Co-operation and Development (OECD), there is a steady increase in the obesity rate until 2030. Obesity rates are projected to increase at a faster pace in Korea where rates have been historically low. This is thus increasing the demand for products in the obesity surgery devices market.

Globally, the key players in the obesity surgery devices market are launching new products to gain a larger market share. For instance, in April 2017, Intuitive Surgical, Inc., announced that the company had received CE Mark approval in Europe for its da Vinci X Surgical system. This approval expanded the company's product portfolio and also provided surgeons and hospitals with advanced robotic assisted surgical technology at an affordable range.

In May 2016, Apollo Endosurgery, Inc., along with Zillion technologies Inc., announced the launch of ORBERA Coach platform that would provide telehealth monitoring of patients undergoing ORBERA Gastric Balloon procedure. ORBERA Coach is a telehealth aftercare program that allows patients to access exercise, nutrition, and other coaching resources via on demand interaction with registered dietitians trained on the ORBERA procedure during the 12 months following placement of the ORBERA gastric balloon. These developments are likely to add to the growth of the obesity surgery devices market.

Other key manufacturers operating in the obesity surgery devices industry include Medtronic plc, Johnson & Johnson, Spatz FGIA Inc., W. L. Gore & Associates, Inc., ReShape Lifesciences, Inc. (formerly EnteroMedics Inc.), and Cousin Biotech.

Market Dynamics

Trend

  • Increasing Demand for Less Invasive Procedures and Gastric Electrical Stimulation for Obesity Surgery

Drivers

  • Increasing Prevalence of Obesity Leading to High Demand for Obesity Surgeries
  • Rising Awareness About Bariatric Surgery Among Obese Population
  • Lifestyle Changes Leading to High Risk of Obesity
  • Technological Advancements in the Obesity Surgery Devices Industry
  • Impact Analysis of Drivers on Market Forecast

Restraints

  • High Cost of Obesity Surgery
  • Risk of Infection and Other Complications Associated With Obesity Surgery
  • Unsuitability of Obesity Surgery to Certain Patient Populations
  • Impact Analysis of Restraints on Market Forecast

Opportunities

  • Favorable Government Initiatives for Research Programs Aimed at Obesity Treatment
  • Favorable Insurance Coverage for Treatment of Obesity

Key Topics Covered

Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Procedure
1.3.2 Market Segmentation by Type
1.3.3 Market Segmentation by Geography
1.3.4 Analysis Period
1.3.5 Market Data Reporting Unit
1.3.5.1 Value
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Procedure
4.1.1.1 Minimally-invasive surgery
4.1.1.1.1 Sleeve gastrectomy surgery (SGS)
4.1.1.1.2 Gastric bypass surgery (GBS)
4.1.1.1.3 Gastric banding surgery
4.1.1.1.4 Biliopancreatic diversion surgeries with a duodenal switch (BPD-DS)
4.1.1.1.5 Others
4.1.1.2 Non-invasive surgeries
4.1.2 By Type
4.1.2.1 Stapling devices
4.1.2.2 Gastric bands
4.1.2.3 Gastric balloons
4.1.2.4 Gastric electrical stimulators
4.1.2.5 Others
4.2 Market Dynamics
4.2.1 Trend
4.2.2 Drivers
4.2.3 Restraints
4.2.4 Opportunities
4.3 Porter's Five Forces Analysis
4.3.1 Bargaining Power of Buyers
4.3.2 Bargaining Power of Suppliers
4.3.3 Intensity of Rivalry
4.3.4 Threat of New Entrants
4.3.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast
5.1 By Procedure
5.1.1 Minimally Invasive Obesity Surgery Devices Market by Type
5.2 By Type
5.3 By Region

Chapter 6. North America Market Size and Forecast
6.1 By Procedure
6.1.1 Minimally Invasive Obesity Surgery Devices Market by Type
6.2 By Type
6.3 By Country

Chapter 7. Europe Market Size and Forecast
7.1 By Procedure
7.1.1 Minimally Invasive Obesity Surgery Devices Market by Type
7.2 By Type
7.3 By Country

Chapter 8. Asia-Pacific Market Size and Forecast
8.1 By Procedure
8.1.1 Minimally Invasive Obesity Surgery Devices Market by Type
8.2 By Type
8.3 By Country

Chapter 9. Latin America Market Size and Forecast
9.1 By Procedure
9.1.1 Minimally Invasive Obesity Surgery Devices Market by Type
9.2 By Type
9.3 By Country

Chapter 10. Middle East & Africa (MEA) Market Size and Forecast
10.1 By Procedure
10.1.1 Minimally Invasive Obesity Surgery Devices Market by Type
10.2 By Type
10.3 By Country

Chapter 11. Competitive Landscape
11.1 Product Benchmarking of Key Players
11.2 Global Strategic Developments of Key Players
11.2.1 Product Launch/Approval
11.2.2 Merger and Acquisition
11.2.3 Others

Chapter 12. Company Profiles
12.1 Medtronic PLC
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.1.3 Key Financial Summary
12.1.4 Strategic Growth Plans
12.2 Johnson & Johnson
12.3 Spatz FGIA Inc.
12.4 W. L. Gore & Associates, Inc.
12.5 Apollo Endosurgery, Inc.
12.6 ReShape Lifesciences, Inc.
12.7 Intuitive Surgical, Inc.
12.8 Cousin Biotech

For more information about this report visit https://www.researchandmarkets.com/research/fbskn8/obesity_surgery?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



View original content:http://www.prnewswire.com/news-releases/obesity-surgery-devices-2017-global-market-report-analysis--forecasts-2013-2023-300615237.html

SOURCE Research and Markets

PR Newswire
www.prnewswire.com

Last updated on: 16/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.